I t is believed that cyclic guanosine monophosphate (cGMP) mediates the relaxation of blood vessels induced by endothelium-derived vascular relaxing factors, the nitrosovasodilators, and atrial natriuretic factor.' However, the mechanisms by which elevations in cGMP can relax vascular smooth muscle cells (VSMC) are not known. It has previously been demonstrated that increases in intracellular calcium and pH of vascular smooth muscle are linked to the contraction of blood vessels. We hypothesized that cGMP could relax vascular smooth muscle by decreasing contractile agonist-induced increases in ionized intracellular calcium, sodiumhydrogen (Na-H) exchange, and intracellular pH.
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Materials and Methods
Cultured A7r5 VSMC from rat thoracic aorta (American Tissue Culture Collection, Rockville, Maryland) were grown to confluence on glass coverslips in Dulbecco's Modified Eagle Medium with HEPES buffer, 13% fetal calf serum (GIBCO, Grand Island, New York), and antibiotics. Intracellular ionized calcium concentration and intracellular pH were measured using microfluorometry with a Gilford Model 404 fluorometer (Cleveland, Ohio) as previously described.
-
5 Briefly, for determination of intracellular ionized calcium concentration, the cells were incubated at 37° C with 10 /JM fura 2-AM (Calbiochem, San Diego, California) for 1 hour. The coverslips were washed and then incubated in a physiological salt solution (PSS) containing 1.6 mM Ca 2+ at pH 7.4. Fluorescence was recorded at 505 nm after alternating excitation at 340 and 380 nm. Intracellular Ca 2+ concentrations were calculated using a dissociation constant of 224 nM as previously described. 45 After baseline fluorescence was measured, either 10" 6 M arginine vasopressin (AVP) (Sigma Chemical Co., St. Louis, Missouri) or 1 unit/ ml a-thrombin (Sigma Chemical Co.) was added, and agonist-induced changes in the ionized calcium concentration were recorded immediately (T ; ) and 5 minutes later (T f ) in the presence and absence of 10" 4 M 8-Br-cGMP (Sigma). Similarly, to study the effect of cGMP on voltage-dependent calcium channels, the responses to depolarizing concentrations of KC1 (80 mM) were measured.
To determine intracellular pH, cells were incubated in 5 fiM of the pH-sensitive dye, biscarboxy-ethylcarboxy-fluorescein (BCECF-AM) (Molecular Probes, Inc., Eugene, Oregon) for 30 minutes and then washed. A calibration curve was constructed by incubating the A7r5 cells in a buffered salt solution in which 130 mM NaCl was isoosmotically replaced with 130 mM KC1 (KSS) and to which 6.9 (iM nigericin (Sigma) was added. The pH of the buffer was titrated between 6.5 and 7.5, and the fluorescence emitted at 525 nm was measured after alternating excitation at 500 and 445 nm. To minimize any contribution to pH by the C1/HCO 3 exchanger in vascular smooth muscle, all experiments were done in HEPES-buffered media. 6 -7 We first determined the effect of 8-Br-cGMP on Na-H antiporter activity in the absence of contractile agonists. Cells were equilibrated in the KSS solution and then washed in a sodium-free PSS. containing nigericin and 130 mM choline chloride at pH 6.5. The coverslips were then placed in the fluorometer cuvette and an isoosmotic HEPESbuffered salt solution containing 30 mM NaCl, 100 mM choline chloride, and 1.6 mM Ca 2+ , at 24° C, pH 7.3, was added. The initial change in fluorescence ratio (Tj) and at 8 minutes (T f ) were measured, and the changes in intracellular pH were calculated by fitting the fluorescence ratio to a value derived from regression analysis of the calibration curve.
The effect of 10~5 M AVP or 1 unit/ml thrombin on intracellular pH of VSMC was determined by adding these agonists to preacidified VSMC to which a 30 mM Na + solution, with and without 10" 3 M 8-Br-cGMP, was added. Again, fluorescence ratios were determined on the initial addition of the agonist and 8 minutes subsequently. Results obtained from the VSMC treated with and without 8-Br-cGMP were analyzed using a Student's unpaired t test with Bonferroni adjustments for multiple comparisons. A p value <0.05 was considered statistically significant.
Results AVP, thrombin, and KC1 induced immediate and significant increases in the ionized intracellular calcium concentrations of the cultured A7r5 cells. All values are expressed as mean±SEM in nanomolars before and after an agonist was added: AVP, from 74±13 to 859±244; thrombin, 30±6 to 331 ±7; and KC1, 94±34 to 432±153. The increase in Ca 2+ induced by AVP and thrombin was maintained for at least 5 minutes; however, KCl-induced increases in Ca 2+ were not maintained ( Figure 1 ). An analogue of cGMP, 10" 4 M 8-Br-cGMP, that enters the cell more readily decreased only AVP-induced increases in Ca 2+ . Although 8-Br-cGMP decreased KClinduced increases in ionized intracellular calcium, the attenuation in the calcium transient was not statistically significant.
Since 8-Br-cGMP is able to relax blood vessels contracted with all of these contractile agonists, it is likely that 8-Br-cGMP is able to relax vascular smooth muscle through multiple mechanisms. Since agonist-induced alkalinization may be linked to increased contractile tone, we studied the effect of 8-Br-cGMP on Na-H antiporter activity. Between pH values of 6.5 and 7.5, fluorescence signals obtained from the cells loaded with BCECF varied directly with pH ( Figure 2 ). Since changes in intracellular pH are small under physiological conditions, we preacidified the cells to amplify any cGMPmediated effects on intracellular pH. When cells were preacidified to pH 6.5 in a sodium-free salt solution, an immediate alkalinization ( Figure 3) was observed upon the readdition of sodium and completed by 8 minutes. We found that cGMP decreases the rapid, initial alkalinization of VSMC induced by activation of the Na-H antiporter.
AVP induced a rapid alkalinization, and the initial, rapid alkalinization was significantly attenuated by 10" 3 M 8-Br-cGMP ( Figure 4) . Thrombin, unlike AVP, induced a transient acidification and subsequent alkalinization of the VSMC. However, this transient acidification induced by thrombin was blocked by 8-Br-cGMP, and this cyclic nucleotide had no effect on the final intracellular pH of thrombintreated cells ( Figure 5 ).
Discussion
The mechanisms by which elevations in cGMP by endothelium-derived vascular relaxing factors, nitrosovasodilators, or ANF are able to relax blood vessels are not known. It is possible that cGMP may decrease receptor binding by contractile agonists, decrease phosphatidylinositol hydrolysis, dependent vasodilators. 10 We found that 8-Br-cGMP decreases AVP-induced increases in Ca 2+ but not those calcium transients induced by thrombin or activation of voltage-dependent calcium channels with high concentrations of potassium.
It has been reported that blood vessels bathed in a calcium-free/EGTA solution contract in response to norepinephrine, but these contractions, presumably caused by intracellular calcium release, were inhibited by cGMP. 11 These findings suggest that cGMP interferes with the release of intracellular calcium or activation of the contractile apparatus by the intracellular calcium. 11 It has been reported that 8-Br-cGMP was ineffective in relaxing precontracted Triton-X skinned vessels, suggesting that only a small fraction of the relaxation of rat aorta with cyclic nucleotides is due to action of these agents at the level of the contractile proteins.•* The cGMPdependent vasodilators nitroglycerine and atrial natriuretic factor have been shown to reduce basal intracellular Ca 2+ concentrations and angiotensin IIinduced increases in Ca 2+ . 1314 Since cGMP did not completely inhibit vasopressin-induced increases in intracellular calcium, it is likely that cGMP acts on selective stores of intracellular calcium.
cGMP has been demonstrated to relax blood vessels contracted with most agonists; yet, cGMP significantly inhibited only the AVP-induced increases in intracellular Ca 2+ . It is suggested from this observation that cGMP must be able to relax blood vessels through other mechanisms.
When VSMC are placed in a sodium-free medium, Na-H exchange is inhibited; hydrogen ions accumulate within the cell, and intracellular pH falls. Readdition of Na + allows for the Na-H antiporter to alkalinize the intracellular milieu. We found that 8-Br-cGMP decreases the rapid, initial alkalinization of VSMC induced by activation of the Na-H antiporter.
We previously noted that contractile responses to varying concentrations of external Ca 2+ in the presence of 1(T 7 M norepinephrine were attenuated when blood vessels were first incubated in an acidic buffer solution (data not shown). When blood vessels are bathed in an acidic medium, the net transport of hydrogen ions out of the cell is decreased, and intracellular pH decreases. It is possible that the decreased contractile responses in blood vessels incubated in low pH is due to intracellular acidification.
We hypothesized that cGMP may decrease contractile tone by decreasing intracellular pH. The mechanisms by which intracellular alkalinization may be coupled to increases in vascular tone are not known.
We found that cGMP decreased AVP-induced alkalinization of VSMC. Thrombin, however, induced a transient acidification that was blocked by 8-Br-cGMP and a subsequent alkalinization. It has been reported by others that thrombin may induce a transient acidification, and this acidification is calcium dependent. 5 It is possible that although cGMP does not inhibit thrombin-induced increases in intracellular calcium, cGMP may interfere with the step that links calcium with a transient acidification. In any event, it is clear that elevations in cGMP may decrease vascular tone by a number of mechanisms, and these mechanisms are dependent on the contractile agonist. There are conflicting reports concerning the relative role of Na-H exchange in the control of vascular tone. 15 We have previously reported that "cGMP-dependent" vasodilation is significantly altered in hypertension. 16 A decrease in vascular cGMP may contribute to the increased Na-H exchange and increased vascular resistance that has been reported to occur in hypertension. 17 
